Alignment Healthcare, Inc. (ALHC) Tops Q2 EPS by 14c

Alignment Healthcare, Inc. (NASDAQ: ALHC) reported Q2 EPS of $0.07, $0.14 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $1 billion versus the consensus estimate of $960.51 million.

Outlook for Third Quarter and Fiscal Year 2025

_______________________

^{(1) Adjusted gross profit and adjusted EBITDA are non-GAAP financial measures presented as supplemental disclosure. We cannot provide estimated ranges for the most directly comparable GAAP measures without unreasonable efforts because of the uncertainty around certain items that may impact such GAAP measures, including equity-based compensation expense and depreciation and amortization, that are not within our control or cannot be reasonably predicted. See “Second Quarter 2025 Non-GAAP Reconciliation Tables” for additional information.}

For earnings history and earnings-related data on Alignment Healthcare, Inc. (ALHC) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Baird sees Tesla-SpaceX merger within 12 to 18 months
• Cushman & Wakefield names two capital markets leaders in APAC